Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorial

  • ·The use of aortic counterpulsation in United States: What can we learn from administrative databases?

    Page :237-238

    Ryan McDonough, E. Magnus Ohman

    

• Results of Expert Meetings

  • ·Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

    Page :239

    Paul L. Hess, Michael J. Mirro, Hans-Christoph Diener, John W. Eikelboom, Sana M. Al-Khatib, Elaine M. Hylek, Hayden B. Bosworth, Bernard J. Gersh, Daniel E. Singer, Greg Flaker, Jessica L. Mega, Eric D. Peterson, John S. Rumsfeld, Benjamin A. Steinberg, Ajay K. Kakkar, Robert M. Califf, Christopher B. Granger, on behalf of the Atrial Fibrillation Think-Tank Participants

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations

    Page :248-255

    Joshua P. Loh, Lakshmana K. Pendyala, Rebecca Torguson, Fang Chen, Lowell F. Satler, Augusto A. Pichard, Ron Waksman

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial

    Page :256-261

    Thomas Pilgrim, Marco Roffi, David Tüller, Olivier Muller, André Vuilliomenet, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Peiman Jamshidi, Dik Heg, Peter Jüni, Stephan Windecker

    Résumé Résumé Plan Plan

• Cardiac Safety Research Consortium

  • ·Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward

    Page :262-272

    Borje Darpo, Christine Garnett, Charles T. Benson, James Keirns, Derek Leishman, Marek Malik, Nitin Mehrotra, Krishna Prasad, Steve Riley, Ignacio Rodriguez, Philip Sager, Nenad Sarapa, Robert Wallis

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·Type of ?-blocker use among patients with versus without diabetes after myocardial infarction

    Page :273

    Suzanne V. Arnold, John A. Spertus, Kasia J. Lipska, David E. Lanfear, Fengming Tang, Anna Grodzinsky, Darren K. McGuire, M. Odette Gore, Abhinav Goyal, Thomas M. Maddox, Mikhail Kosiborod

    Résumé Résumé Plan Plan  
  • ·Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: The randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study

    Page :280

    Anne Pernille Ofstad, Odd Erik Johansen, Lars Gullestad, Kåre I. Birkeland, Elsa Orvik, Morten W. Fagerland, Stig Urheim, Svend Aakhus

    Résumé Résumé Plan Plan  
  • ·The role of primary care physician and cardiologist follow-up for low-risk patients with chest pain after emergency department assessment

    Page :289-295

    Andrew Czarnecki, Julie T. Wang, Jack V. Tu, Douglas S. Lee, Michael J. Schull, Ching Lau, Michael E. Farkouh, Harindra C. Wijeysundera, Dennis T. Ko

    Résumé Résumé Plan Plan  
  • ·Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study

    Page :296-302

    Aaron R. Folsom, Alvaro Alonso, Jeffrey R. Misialek, Erin D. Michos, Elizabeth Selvin, John H. Eckfeldt, Josef Coresh, James S. Pankow, Pamela L. Lutsey

    Résumé Résumé Plan Plan
  • ·Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Page :303-309

    Shinya Goto, Jun Zhu, Lisheng Liu, Byung-Hee Oh, Daniel M. Wojdyla, Philip Aylward, M. Cecilia Bahit, Bernard J. Gersh, Michael Hanna, John Horowitz, Renato D. Lopes, Lars Wallentin, Denis Xavier, John H. Alexander, ARISTOTLE Investigators

    Résumé Résumé Plan Plan  
  • ·Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention

    Page :310

    Lisa Tully, Eugenia Gianos, Anish Vani, Yu Guo, Revathi Balakrishnan, Arthur Schwartzbard, James Slater, Richard Stein, James Underberg, Howard Weintraub, Edward Fisher, Jeffrey S. Berger

    Résumé Résumé Plan Plan  
  • ·Cardiac troponin I levels in patients with non–ST-elevation acute coronary syndrome—The importance of gender

    Page :317

    Kai M. Eggers, Nina Johnston, Stefan James, Bertil Lindahl, Per Venge

    Résumé Résumé Plan Plan  
  • ·Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation

    Page :325-331

    Ulrik Sartipy, Ayumi Goda, Melana Yuzefpolskaya, Donna M. Mancini, Lars H. Lund

    Résumé Résumé Plan Plan  
  • ·Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement

    Page :332-339

    Daniele Andreini, Gianluca Pontone, Saima Mushtaq, Antonio L. Bartorelli, Giovanni Ballerini, Erika Bertella, Chiara Segurini, Edoardo Conte, Andrea Annoni, Andrea Baggiano, Alberto Formenti, Laura Fusini, Gloria Tamborini, Francesco Alamanni, Cesare Fiorentini, Mauro Pepi

    Résumé Résumé Plan Plan  
  • ·Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: Insights from the Veterans Affairs CART Program

    Page :340-345

    James B. Byrd, Thomas M. Maddox, Colin I. O'Donnell, Gary K. Grunwald, Deepak L. Bhatt, Thomas T. Tsai, John S. Rumsfeld, P. Michael Ho

    Résumé Résumé Plan Plan  
  • ·Spironolactone lowers the rate of repeat revascularization in acute myocardial infarction patients treated with percutaneous coronary intervention

    Page :346

    Pil Sang Song, Dong-Kie Kim, Guang-Won Seo, Ki-Hun Kim, Sang-Hoon Seol, Jeong Hoon Yang, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Hyeon-Cheol Gwon, Youngkeun Ahn, Myung Ho Jeong, Young Bin Song, Doo-Il Kim, Other Korea Acute Myocardial Infarction Registry Investigators

    Résumé Résumé Plan Plan  
  • ·Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data

    Page :354

    Marieke L. Fokkema, Peter van der Meer, Sunil V. Rao, Anne M. Belonje, Maurizio Ferrario, Hans L. Hillege, Stuart D. Katz, Erik Lipšic, Andrew J. Ludman, Ilka Ott, Fabrice Prunier, Dong-Ju Choi, Ken Toba, Dirk J. van Veldhuisen, Adriaan A. Voors

    Résumé Résumé Plan Plan  
  • ·Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008

    Page :363

    Hiren Patel, Anupama Shivaraju, Gregg C. Fonarow, Hui Xie, Weihua Gao, Adhir R. Shroff, Mladen I. Vidovich

    Résumé Résumé Plan Plan  
  • ·Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial

    Page :374-380

    Manuel Pan, Alfonso Medina, Miguel Romero, Soledad Ojeda, Pedro Martin, Javier Suarez de Lezo, Jose Segura, Francisco Mazuelos, Jose Novoa, Jose Suarez de Lezo

    Résumé Résumé Plan Plan  
  • ·Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

    Page :381

    Steven M. Bradley, Maggie A. Stanislawski, David B. Bekelman, Lindsey L. Monteith, Beth E. Cohen, John H. Schilling, Stephen C. Hunt, Debra Milek, Thomas M. Maddox, P. Michael Ho, Supriya Shore, Paul D. Varosy, Monica M. Matthieu, John S. Rumsfeld

    Résumé Résumé Plan Plan  
  • ·Electrocardiographic abnormalities and coronary artery calcium for coronary heart disease prediction and reclassification: The Multi-Ethnic Study of Atherosclerosis (MESA)

    Page :391-397

    Chintan S. Desai, Hongyan Ning, Elsayed Z. Soliman, Gregory L. Burke, Steven Shea, Saman Nazarian, Donald M. Lloyd-Jones, Philip Greenland

    Résumé Résumé Plan Plan  
  • ·Current quality of cardiovascular prevention for Million Hearts: An analysis of 147,038 outpatients from The Guideline Advantage

    Page :398-404

    Zubin J. Eapen, Li Liang, Jay H. Shubrook, Mary A. Bauman, Vincent J. Bufalino, Deepak L. Bhatt, Eric D. Peterson, Adrian F. Hernandez

    Résumé Résumé Plan Plan